Sulodexide as pharmacotherapy for protection of endothelium and suppression of thrombosis in COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sulodexide as pharmacotherapy for protection of endothelium and suppression of thrombosis in COVID-19

Published:2022-01-21 Issue:2 Volume:11 Page:6-17
ISSN:2658-5952
Container-title:Aterotromboz = Atherothrombosis
language:
Short-container-title:Aterotromboz

Author:

Melkumyants A. M.¹^ORCID,Buryachkovskaya L. I.²^ORCID,Lomakin N. V.³,Antonova O. A.²^ORCID,Ermiskin V. V.²^ORCID,Dotsenko Y. V.²

Affiliation:

1. National Medical Research Center of Cardiology; Moscow Institute of Physics and Technology (National Research University)

2. National Medical Research Center of Cardiology

3. Central Clinical Hospital with Polyclinic of the Office of the President of the Russian Federation

Publisher

Remedium, Ltd.

Reference49 articles.

1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. https://doi.org/10.1056/NEJMoa2001017.

2. Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782–793. https://doi.org/10.1001/jama.2020.12839.

3. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395(10223):507–513. https://doi.org/10.1016/S0140-6736(20)30211-7.

4. Prabakaran P., Xiao X., Dimitrov D.S. A model of the ACE2 structure and function as a SARS-CoV receptor. Biochem Biophys Res Commun. 2004;314(1):235–241. https://doi.org/10.1016/j.bbrc.2003.12.081.

5. Zaim S., Chong J.H., Sankaranarayanan V., Harky A. COVID-19 and multi-organ response. Curr Probl Cardiol. 2020;45(8):100618. https://doi.org/10.1016/j.cpcardiol.2020.100618.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possibilities of sulodexide use in clinical practice;Meditsinskiy sovet = Medical Council;2023-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3